The Valley Desk

NCT00516893 · Interventional trial

Natalizumab High Titer Immunogenicity and Safety

Overall registry status Completed

Phase 2

Conditions Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov